CPT® Code 90697

1. Indications

The combination vaccine represented by CPT® Code 90697 is indicated for the prevention of several serious infectious diseases. The specific indications include:

• Diphtheria: A bacterial infection that can lead to severe respiratory issues and complications due to the toxin produced by the bacteria.
• Tetanus: A serious condition caused by a neurotoxin that results in painful muscle contractions and can be life-threatening.
• Pertussis (Whooping Cough): An acute respiratory infection characterized by severe coughing fits that can lead to complications, especially in infants and young children.
• Poliovirus: A virus that can cause inflammation of the spinal cord and brain, leading to paralysis and other serious neurological complications.
• Haemophilus influenzae type b (Hib): A bacterium that can cause severe infections such as meningitis, pneumonia, and sepsis, particularly in young children.
• Hepatitis B: A viral infection that affects the liver and can lead to chronic liver disease, liver cancer, and death.

2. Procedure

The administration of the DTaP-IPV-Hib-HepB combination vaccine involves several procedural steps, which are outlined as follows:

• Step 1: The healthcare provider prepares the vaccine for administration. This includes checking the vaccine's expiration date, ensuring proper storage conditions, and shaking the vial gently to mix the components if necessary.
• Step 2: The provider selects an appropriate site for intramuscular injection, typically the deltoid muscle in the upper arm for older children and adults, or the anterolateral thigh for infants and young children.
• Step 3: The provider cleans the injection site with an antiseptic wipe to reduce the risk of infection.
• Step 4: Using a sterile syringe and needle, the provider draws the correct dosage of the vaccine from the vial.
• Step 5: The provider inserts the needle into the muscle at the appropriate angle and injects the vaccine slowly and steadily.
• Step 6: After the injection, the provider withdraws the needle and applies gentle pressure to the injection site with a cotton ball or gauze to minimize bleeding.
• Step 7: The provider disposes of the needle and syringe in a sharps container and documents the administration in the patient's medical record, including the date, time, site of injection, and any observations made during the procedure.

3. Post-Procedure

After the administration of the DTaP-IPV-Hib-HepB combination vaccine, the patient is typically monitored for a short period to observe for any immediate adverse reactions, such as allergic responses. Common post-procedure care includes advising the patient or caregiver about potential mild side effects, which may include soreness at the injection site, low-grade fever, or irritability. It is important to inform them that these reactions are generally mild and resolve on their own. Patients should be instructed to seek medical attention if they experience any severe or unusual symptoms following vaccination. Additionally, documentation of the vaccine administration should be maintained in the patient's immunization record for future reference and to ensure compliance with vaccination schedules.